Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

NCT01093300 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

264

Enrollment

OTHER

Sponsor class

Conditions

In-stent Restenosis Lesion

Interventions

DEVICE: Paclitaxel-eluting balloon catheter
DEVICE: Everolimus-eluting stent

Sponsor

Seoul National University Hospital